Compounding Hotline

Martin A. Erickson III, RPh
Published Online: Saturday, November 1, 2008

Mr. Erickson is director of professional affairs at Gallipot Inc.

A physician wants to substitute dehydroepiandrosterone (DHEA) for 7-keto-DHEA milligram for milligram. What is the appropriate dosing approach?


These moieties are not interchangeable. Authorities vary—some claim that 7-keto-DHEA is not metabolized to androgens and estrogens, whereas others claim that the metabolic pathway leads to conversion. In any case, DHEA is metabolized to 7-keto-DHEA.

A literature search for dosing information returned an inconclusive result. It appears that the daily dose of 7-keto-DHEA for adults is about half that for DHEA, however.

Compounding pharmacists should also be aware of adverse regulatory findings where therapeutic claims were made for dietary substances such as DHEA.


What is the importance of the cps in the cellulose derivatives?


The number preceding the ?cps? designation (eg, 4000 cps) is viscosity in centipoise of a 2% solution of the material at room temperature. For compounding, recall that the higher the cps number, the more viscous will be the preparation with the same concentration of material. Generally, use hypromellose (methylcellulose) 1500 cps for gel as a suspending agent. Compound as a 1% solution; use as 50% of the preparation?s vehicle. The other 50% will be active ingredient(s), excipient(s), etc, and syrup (flavored) to make methylcellulose 0.5% final concentration.

E-mail your compounding questions to .

Latest Articles
In case you got caught up in the Thanksgiving holiday rush, here are the top trending stories you may have missed in November:
Bryan Ziegler, PharmD, executive director of Kennedy Pharmacy Innovation Center, provides some resources for community pharmacists to use when implementing new collaborative services with primary care providers.
James Schiffer, RPh, associate at Allegaert Berger & Vogel LLC, discusses some tips for pharmacists who are facing a Drug Enforcement Administration audit.
Carlos Aquino, founder and president of PharmaDiversion LLC, talks about the importance of the Drug Enforcement Administration's (DEA) diversion website.
Latest Issues